Publications by authors named "Haesook Kim"

Claim this Profile
V
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor risk MDS/AML.
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Anna Bosch-Vilaseca, Kevin M Panaro

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.
H Moses Murdock, Haesook T Kim, Katie Maurer, Amar H Kelkar, Roman M Shapiro

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced incidence of relapse and graft--host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation.
Haesook T Kim, Robert J Soiffer, Corey Cutler, John Koreth, Sarah Nikiforow

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Myelofibrosis.
Haesook T Kim, Deborah J Liney, Kristen Rizza, Corey S Cutler, John Koreth

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in Shared Care Research in Hematopoietic Cell Transplantation-Reply.
Gregory A Abel, Haesook T Kim, Robert J Soiffer

JAMA Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation.
Nicoletta Cieri, Nidhi Hookeri, Kari Stromhaug, Liang Li, Julia Keating, Haesook T Kim

Nat Biotechnol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT.
Zachariah DeFilipp, Haesook T Kim, Laura W Knight, Suzanne M O'Connor, Shilton E Dhaver

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all- retinoic acid.
Wellington F Silva, Haesook T Kim, Maria S Undurraga, Juan R Navarro-Cabrera, Victor Salinas

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared Local Oncology Care After Allogeneic Hematopoietic Cell Transplantation: A Randomized Clinical Trial.
Gregory A Abel, Haesook T Kim, Ira Zackon, Edwin T Alyea, Alexandra S Bailey

JAMA Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection or Disease or with Concurrent Organ Dysfunction: A Phase 2 Open Label Study.
Matthew P Cheng, Isabel H Gonzalez-Bocco, Esther Arbonna-Haddad, Muneerah Aleissa, Kaiwen Chen, Haesook T Kim

J Assoc Med Microbiol Infect Dis Can· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT.
Zachariah DeFilipp, Haesook T Kim, Guang-Shing Cheng, Betty K Hamilton, Saurabh Chhabra

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations.
Livius Penter, Nicoletta Cieri, Katie Maurer, Marwan Kwok, Haoxiang Lyu, Haesook T Kim

Blood Cancer Discov· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survival.
Roman M Shapiro, Haesook T Kim, Remy Dulery, Deborah Liney, Heather M Garrity

Blood Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia.
Luísa Corrêa de Araújo Koury, Haesook T Kim, Maria Soledad Undurraga, Juan Ramon Navarro-Cabrera, Victor Salinas

Blood· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD.
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk

Blood Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis.
Haesook T Kim, Vincent T Ho, Sarah Nikiforow, Corey Cutler, John Koreth

Transplant Cell Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of COVID-19 in children and adolescents with diabetes in Daegu, South Korea.
Na-Won Lee, You-Min Kim, Young-Hwan Kim, Seok-Jin Kang, Kyung-Mi Jang, Hae-Sook Kim, Jin-Kyung Kim

Ann Pediatr Endocrinol Metab· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract.
Zachariah DeFilipp, Ashish V Damania, Haesook T Kim, Chia-Chi Chang, Areej El-Jawahri

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competing risks data in clinical oncology.
Haesook Teresa Kim

Front Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinicopathological Appraisal of Duodenal Neuroendocrine Tumors at a Racially Diverse Safety Net Hospital.
Sofia D Shaikh, Isa Jacoba, Natalie Sun, Enoch Chung, Haesook T Kim

Am J Gastroenterol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML.
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, Michela Ansuinelli, Jennifer Brock

Blood Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD.
Katie Maurer, Vincent T Ho, Eno Inyang, Corey Cutler, John Koreth, Haesook T Kim

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse.
Roman M Shapiro, Haesook T Kim, Michela Ansuinelli, Indira Guleria, Corey S Cutler

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy.
Pavan Bachireddy, Elham Azizi, Cassandra Burdziak, Vinhkhang N Nguyen, Christina S Ennis, Haesook T Kim

Cell Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease.
Holly Wobma, Malika Kapadia, Haesook T Kim, Francesca Alvarez-Calderon, Susanne H C Baumeister

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis